在缺血性心力衰竭中多态成像
Jeroen J Bax1, Marcelo Di Carli2, Jagat Narula3
1Department of Cardiology, Leiden University Medical Center, Leiden, Netherlands.
Lancet (London, England)
|March 13, 2019
概括
现代的非侵入性成像对于评估心力衰竭的原因,指导预后以及确定再血管化或门修复等疗法至关重要. 这种评估有助于选择最佳的治疗方法.
科学领域:
- 心脏病学
- 医学成像
背景情况:
- 需要对心脏衰竭的原因,病理生理学和血液动力学进行全面评估.
- 现代的非侵入性成像方法对于评估心脏结构和功能至关重要.
研究的目的:
- 使用非侵入性成像评估心力衰竭的系统方法.
- 突显成像如何指导治疗决策,
主要方法:
- 逐步评估左心室的大小和功能.
- 评估冠状动脉疾病,心肌吐,肺高血压和右心室功能.
- 评估三角吐情况.
主要成果:
- 非侵入性成像为预后和治疗计划提供关键数据.
- 图像检测结果可以指导重新血管化,除器植入和门修复/更换的决策.
- 随机对照试验中指导非侵入性成像治疗的证据有限.
结论:
- 对心力衰竭患者进行全面的非侵入性成像策略至关重要.
- 图像对心力衰竭的个性化治疗策略起着关键作用.
- 需要进一步的研究来加强心力衰竭的成像指导治疗的证据基础.
相关概念视频
Pathophysiology of Heart Failure
3.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.4K
Heart Failure I: Introduction
829
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
829
Heart Failure II: Pathophysiology
855
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
855
Heart Failure Drugs: Diuretics
935
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
935
Heart Failure V: Medical Management
267
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
267
Heart Failure VI: Adjunct Therapies
313
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
313


